전이성 췌장암에서 젬시타빈 단독 요법 후 완전관해 유사 반응을 보인 1예

초록

Pancreatic cancer is well known to have a very poor prognosis that is under 5% of five years survival rate. Especially, metastatic pancreatic cancer has poor responses to both of chemotherapy and radiation therapy. There are many clinical trials of variable chemo-regimens, but there is no proved regimen better than gemcitabine based therapy. A 71 years old male patient was diagnosed with 2.8 × 1.9cm sized advanced pancreatic body cancer with liver, mediastinal and both supraclavicular lymph nodes, right ischial bone metastasis in July, 2011. He was taken chemotherapy of gemcitabine single regimen, and his radiological findings after 10th cycles of chemotherapy revealed a near complete response. The authors report this rare case of near complete response with gemcitabine single chemotherapy in advanced pancreatic cancer with multiple metastasis.

키워드